APYX MEDICAL CORP (APYX)
US03837C1062 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 43.65M | 10.19M | 30.87M | 41.92M | 58.81M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | 0.00 | |||
| Receivables | 14.15M | 18.35M | 21.26M | 17.33M | 9.22M | |||
| Inventories | 9.92M | 11.80M | 6.78M | 4.05M | 5.07M | |||
| Other Current Assets | 2.63M | 2.64M | 1.83M | 2.80M | 3.63M | |||
| Total Current Assets | 70.36M | 42.97M | 60.74M | 66.09M | 76.73M | |||
| Non-Current Assets | ||||||||
| PPE Net | 7.15M | 7.59M | 6.87M | 7.22M | 7.62M | |||
| Goodwill | N/A | N/A | N/A | N/A | N/A | |||
| Intangibles | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 1.73M | 1.22M | 1.11M | 810.00K | 390.00K | |||
| Total Non-Current Assets | 8.88M | 8.81M | 7.98M | 8.02M | 8.02M | |||
| TOTAL ASSETS | 79.24M | 51.78M | 68.72M | 74.11M | 84.75M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 20.00K | 40.00K | 170.00K | 240.00K | 370.00K | |||
| Accrued Expenses | 9.52M | 6.21M | 8.55M | 5.75M | 8.01M | |||
| Accounts Payable | 2.71M | 2.67M | 2.63M | 1.51M | 2.44M | |||
| Other Current Liabilities | 488.00K | 2.93M | 1.86M | 1.66M | 1.49M | |||
| Total Current Liabilities | 12.74M | 11.85M | 13.21M | 9.15M | 12.31M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 33.24M | 70.00K | 20.00K | 180.00K | 420.00K | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Liabilities | 6.34M | 2.06M | 1.49M | 920.00K | 750.00K | |||
| Total Non-Current Liabilities | 39.80M | 2.34M | 1.81M | 1.24M | 1.18M | |||
| TOTAL LIABILITIES | 52.54M | 14.19M | 15.02M | 10.39M | 13.49M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -54.45M | -35.74M | -12.55M | 2.62M | 14.52M | |||
| Additional Paid In Capital | 81.11M | 73.28M | 66.22M | 61.07M | 56.71M | |||
| Minority Interest | 358.00K | 300.00K | 340.00K | 150.00K | N/A | |||
| Common Shares | 35.00K | 40.00K | 30.00K | 30.00K | 30.00K | |||
| Shares Outstanding | 34.64M | 34.60M | 34.41M | 34.29M | 34.17M | |||
| Tangible Book Value per Share | 0.77 | 1.09 | 1.56 | 1.86 | 2.09 | |||
| Total Shareholders' Equity | 26.70M | 37.58M | 53.70M | 63.72M | 71.26M | |||
| TOTAL LIABILITIES AND EQUITY | 79.24M | 51.78M | 68.72M | 74.11M | 84.75M | |||
| Statistics | ||||||||
| Debt/Equity | 1.24 | 0.00 | 0.00 | 0.00 | 0.01 | |||
| Current Ratio | 5.52 | 3.63 | 4.60 | 7.22 | 6.23 | |||
| Return On Assets (ROA) | -23.62% | -44.77% | -22.08% | -16.06% | -23.26% | |||
| Return On Equity (ROE) | -70.08% | -61.68% | -28.25% | -18.68% | -27.66% | |||
All data in USD